Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection
Breast cancer (BC) remains the second leading cause of death among women worldwide. An emerging approach based on the identification of endogenous metabolites (EMs) and the establishment of the metabolomic fingerprint of biological fluids constitutes a new frontier in medical diagnostics and a promi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/9/11/269 |
id |
doaj-3dd2f2d1228d4ab5a12b7b90d8abfadb |
---|---|
record_format |
Article |
spelling |
doaj-3dd2f2d1228d4ab5a12b7b90d8abfadb2020-11-25T02:27:49ZengMDPI AGMetabolites2218-19892019-11-0191126910.3390/metabo9110269metabo9110269Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer DetectionCatarina L. Silva0Ana Olival1Rosa Perestrelo2Pedro Silva3Helena Tomás4José S. Câmara5CQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, PortugalCQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, PortugalCQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, PortugalCQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, PortugalCQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, PortugalCQM—Centro de Química da Madeira, Universidade da Madeira, Campus Universitário da Penteada, 9020-105 Funchal, PortugalBreast cancer (BC) remains the second leading cause of death among women worldwide. An emerging approach based on the identification of endogenous metabolites (EMs) and the establishment of the metabolomic fingerprint of biological fluids constitutes a new frontier in medical diagnostics and a promising strategy to differentiate cancer patients from healthy individuals. In this work we aimed to establish the urinary metabolomic patterns from 40 BC patients and 38 healthy controls (CTL) using proton nuclear magnetic resonance spectroscopy (1H-NMR) as a powerful approach to identify a set of BC-specific metabolites which might be employed in the diagnosis of BC. Orthogonal partial least squares-discriminant analysis (OPLS-DA) was applied to a 1H-NMR processed data matrix. Metabolomic patterns distinguished BC from CTL urine samples, suggesting a unique metabolite profile for each investigated group. A total of 10 metabolites exhibited the highest contribution towards discriminating BC patients from healthy controls (variable importance in projection (VIP) >1, <i>p</i> < 0.05). The discrimination efficiency and accuracy of the urinary EMs were ascertained by receiver operating characteristic curve (ROC) analysis that allowed the identification of some metabolites with the highest sensitivities and specificities to discriminate BC patients from healthy controls (e.g. creatine, glycine, trimethylamine N-oxide, and serine). The metabolomic pathway analysis indicated several metabolism pathway disruptions, including amino acid and carbohydrate metabolisms, in BC patients, namely, glycine and butanoate metabolisms. The obtained results support the high throughput potential of NMR-based urinary metabolomics patterns in discriminating BC patients from CTL. Further investigations could unravel novel mechanistic insights into disease pathophysiology, monitor disease recurrence, and predict patient response towards therapy.https://www.mdpi.com/2218-1989/9/11/269breast cancer<sup>1</sup>h nmrurinemetabolomicschemometric tools |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Catarina L. Silva Ana Olival Rosa Perestrelo Pedro Silva Helena Tomás José S. Câmara |
spellingShingle |
Catarina L. Silva Ana Olival Rosa Perestrelo Pedro Silva Helena Tomás José S. Câmara Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection Metabolites breast cancer <sup>1</sup>h nmr urine metabolomics chemometric tools |
author_facet |
Catarina L. Silva Ana Olival Rosa Perestrelo Pedro Silva Helena Tomás José S. Câmara |
author_sort |
Catarina L. Silva |
title |
Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection |
title_short |
Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection |
title_full |
Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection |
title_fullStr |
Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection |
title_full_unstemmed |
Untargeted Urinary <sup>1</sup>H NMR-Based Metabolomic Pattern as a Potential Platform in Breast Cancer Detection |
title_sort |
untargeted urinary <sup>1</sup>h nmr-based metabolomic pattern as a potential platform in breast cancer detection |
publisher |
MDPI AG |
series |
Metabolites |
issn |
2218-1989 |
publishDate |
2019-11-01 |
description |
Breast cancer (BC) remains the second leading cause of death among women worldwide. An emerging approach based on the identification of endogenous metabolites (EMs) and the establishment of the metabolomic fingerprint of biological fluids constitutes a new frontier in medical diagnostics and a promising strategy to differentiate cancer patients from healthy individuals. In this work we aimed to establish the urinary metabolomic patterns from 40 BC patients and 38 healthy controls (CTL) using proton nuclear magnetic resonance spectroscopy (1H-NMR) as a powerful approach to identify a set of BC-specific metabolites which might be employed in the diagnosis of BC. Orthogonal partial least squares-discriminant analysis (OPLS-DA) was applied to a 1H-NMR processed data matrix. Metabolomic patterns distinguished BC from CTL urine samples, suggesting a unique metabolite profile for each investigated group. A total of 10 metabolites exhibited the highest contribution towards discriminating BC patients from healthy controls (variable importance in projection (VIP) >1, <i>p</i> < 0.05). The discrimination efficiency and accuracy of the urinary EMs were ascertained by receiver operating characteristic curve (ROC) analysis that allowed the identification of some metabolites with the highest sensitivities and specificities to discriminate BC patients from healthy controls (e.g. creatine, glycine, trimethylamine N-oxide, and serine). The metabolomic pathway analysis indicated several metabolism pathway disruptions, including amino acid and carbohydrate metabolisms, in BC patients, namely, glycine and butanoate metabolisms. The obtained results support the high throughput potential of NMR-based urinary metabolomics patterns in discriminating BC patients from CTL. Further investigations could unravel novel mechanistic insights into disease pathophysiology, monitor disease recurrence, and predict patient response towards therapy. |
topic |
breast cancer <sup>1</sup>h nmr urine metabolomics chemometric tools |
url |
https://www.mdpi.com/2218-1989/9/11/269 |
work_keys_str_mv |
AT catarinalsilva untargetedurinarysup1suphnmrbasedmetabolomicpatternasapotentialplatforminbreastcancerdetection AT anaolival untargetedurinarysup1suphnmrbasedmetabolomicpatternasapotentialplatforminbreastcancerdetection AT rosaperestrelo untargetedurinarysup1suphnmrbasedmetabolomicpatternasapotentialplatforminbreastcancerdetection AT pedrosilva untargetedurinarysup1suphnmrbasedmetabolomicpatternasapotentialplatforminbreastcancerdetection AT helenatomas untargetedurinarysup1suphnmrbasedmetabolomicpatternasapotentialplatforminbreastcancerdetection AT josescamara untargetedurinarysup1suphnmrbasedmetabolomicpatternasapotentialplatforminbreastcancerdetection |
_version_ |
1724840705714552832 |